Join the Geographic atrophy group to help and get support from people like you.
Geographic atrophy News
Related terms: GA
Robotic Procedure Helps Treat Macular Degeneration
THURSDAY, June 12, 2024 – Robot-guided radiation therapy can improve treatment for age-related macular degeneration, the leading cause of vision loss and blindness among American seniors, a new...
Robotic Procedure Helps Treat Macular Degeneration
THURSDAY, June 12, 2024 – Robot-guided radiation therapy can improve treatment for age-related macular degeneration, the leading cause of vision loss and blindness among American seniors, a new...
Melatonin Use Linked to Reduced Risk for Development, Progression of AMD
TUESDAY, June 11, 2024 – Melatonin use is associated with a reduced risk for development and progression of age-related macular degeneration (AMD), according to a study published online June 6 in...
Minocycline Does Not Decrease Geographic Atrophy Enlargement in AMD
MONDAY, March 25, 2024 – Oral minocycline is not associated with a decrease in geographic atrophy (GA) enlargement in patients with age-related macular degeneration (AMD), according to a study...
FDA Approves Izervay for Geographic Atrophy Tied to Age-Related Macular Degeneration
WEDNESDAY, Aug. 9, 2023 – The U.S. Food and Drug Administration has approved Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy secondary to age-related...
FDA Approves Izervay (avacincaptad pegol) Intravitreal Solution for the Treatment for Geographic Atrophy
TOKYO, Aug. 5, 2023 /PRNewswire/ – Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas"), today announced the U.S. Food and Drug Administration (FDA) approved Izervay™ (...
Ask a question
To post your own question to this support group, sign in or create an account.